Literature DB >> 11123003

Pharmacotherapies for cocaine dependence.

G O'Leary1, R D Weiss.   

Abstract

This article reviews the history of pharmacologic trials for the treatment of cocaine dependence as well as current treatments under investigation. The rationale for use of agents such as dopaminergic agents, antidepressants, and anticonvulsants is discussed. Early clinical trials with pharmacologic agents have demonstrated both positive and negative results; the possible reasons for these mixed outcomes is also discussed. Recent studies focusing on disulfiram, dopamine-selective antagonists, citicoline, aspirin, and a cocaine-specific vaccine are presented to highlight innovative and potentially effective treatments for individuals with cocaine dependence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123003     DOI: 10.1007/s11920-000-0010-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  66 in total

1.  A comparison of male and female cocaine abusers.

Authors:  M L Griffin; R D Weiss; S M Mirin; U Lange
Journal:  Arch Gen Psychiatry       Date:  1989-02

2.  A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.

Authors:  W M Clark; S J Warach; L C Pettigrew; R E Gammans; L A Sabounjian
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

3.  A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients.

Authors:  T R Kosten; B Schumann; D Wright; M K Carney; F H Gawin
Journal:  J Clin Psychiatry       Date:  1987-11       Impact factor: 4.384

4.  Psychopathology in cocaine abusers. Changing trends.

Authors:  R D Weiss; S M Mirin; M L Griffin; J L Michael
Journal:  J Nerv Ment Dis       Date:  1988-12       Impact factor: 2.254

5.  Disulfiram therapy in patients abusing cocaine and alcohol.

Authors:  S T Higgins; A J Budney; W K Bickel; J R Hughes; F Foerg
Journal:  Am J Psychiatry       Date:  1993-04       Impact factor: 18.112

6.  Chronic disulfiram treatment effects on intranasal cocaine administration: initial results.

Authors:  E F McCance-Katz; T R Kosten; P Jatlow
Journal:  Biol Psychiatry       Date:  1998-04-01       Impact factor: 13.382

7.  Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.

Authors:  T P George; M C Chawarski; J Pakes; K M Carroll; T R Kosten; R S Schottenfeld
Journal:  Biol Psychiatry       Date:  2000-06-15       Impact factor: 13.382

8.  Acetylation of prostaglandin synthase by aspirin.

Authors:  G J Roth; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

9.  Disulfiram and erythrocyte aldehyde dehydrogenase inhibition.

Authors:  J F Towell; J K Cho; B L Roh; R I Wang
Journal:  Clin Pharmacol Ther       Date:  1983-04       Impact factor: 6.875

10.  Fluoxetine alters the effects of intravenous cocaine in humans.

Authors:  S L Walsh; K L Preston; J T Sullivan; R Fromme; G E Bigelow
Journal:  J Clin Psychopharmacol       Date:  1994-12       Impact factor: 3.153

View more
  2 in total

Review 1.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

2.  Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.

Authors:  Frances R Levin; John J Mariani; Sheila Specker; Marc Mooney; Amy Mahony; Daniel J Brooks; David Babb; Yun Bai; Lynn E Eberly; Edward V Nunes; John Grabowski
Journal:  JAMA Psychiatry       Date:  2015-06       Impact factor: 21.596

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.